Adalimumab vs Trastuzumab

## Adalimumab vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Trastuzumab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Adalimumab — Antibody; Trastuzumab — Antibody.